Key result
Controlled volume loss from blood donation was accurately detected by a reduction in cardiac index measured via the non-invasive Nexfin device.
Why the study?
Does the Nexfin device accurately detect controlled volume loss in spontaneously breathing whole-blood donors?
Observational (n=40)
Does the Nexfin device accurately detect controlled volume loss in spontaneously breathing whole-blood donors?
The Nexfin non-invasive haemodynamic monitor can feasibly detect volaemic changes in spontaneously breathing subjects, particularly using cardiac index and systemic vascular resistance.
Answers are grounded in this paper and cite their sources.
Supports Nexfin feasibility for volaemic detection in awake subjects; leaves open validation before perioperative use.
We investigated which haemodynamic parameters derived from Nexfin non-invasive continuous arterial blood pressure measurements are optimal to detect controlled volume loss in spontaneously breathing subjects. Haemodynamic monitoring was performed in 40 whole-blood donors. Mean arterial pressure, cardiac index, systemic vascular resistance index and pulse pressure variation were recorded during controlled breathing, and a Valsalva manoeuvre was performed before and after blood donation. Blood donation resulted in a reduction in cardiac index (from 3.96 ± 0.84 l.min(-1) .m(2) to 3.30 ± 0.61 l.min(-1) .m(2) ; p < 0.001), an increase in systemic vascular resistance (from 1811 ± 450 dyn.s.cm(-5) .m(2) to 2137 ± 428 dyn.s.cm(-5) .m(2) ; p < 0.001) and an increase in pulse pressure variation (from 13.4 ± 5.1 to 15.3 ± 5.4%; p = 0.02). The area under the receiver operating characteristic curve to detect volume loss was highest for cardiac index (0.94, 95% CI 0.88-0.99) and systemic vascular resistance (0.90, 95% CI 0.82-0.99). Nexfin is a non-invasive haemodynamic monitor that can feasibly detect volaemic changes in spontaneously breathing subjects.
No takes yet. Share an insight, caveat, or question.
Nicia et al. (2015) conducted an observational in Whole-blood donors (n=40). Controlled volume loss (blood donation) vs. Baseline (before blood donation) was evaluated on Detection of volume loss (AUC for cardiac index) (AUC 0.94, 95% CI 0.88-0.99, p=<0.001). Controlled volume loss from blood donation was accurately detected by a reduction in cardiac index measured via the non-invasive Nexfin device.
Synapse has enriched 10 related papers. Consider them for comparative context: